Fibroblast growth factor 21 serum levels in diabetes mellitus patients: assessment of their correlation with carbohydrate and lipid metabolism markers
Review of Clinical Pharmacology and Pharmacokinetics - International Edition · 2025
DOI: 10.61873/bbdf1129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Review of Clinical Pharmacology and Pharmacokinetics - International Edition, 2025. Verfasst von Maria Trapali und 3 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Fibroblast growth factor 21 (FGF21 regulates several biochemical pathways such as glucose/fructose update, lipid oxidation, and insulin/glycogen sensitivity. Some beneficial effects of FGF21 on human body have been investigated, including weight loss and improved glycemia. It has been also suggested as a therapeutic agent for Diabetes Type 2.
Aim
Τhe aim of this study is to measure FGF21 serum levels in diabetes mellitus patients, compare them with FGF21 levels in healthy individuals and correlate them with age, carbohydrate and lipid metabolism markers. Methodology: In this study. FGF21 levels in 35 diabetics and 23 non-diabetics were correlated with Glucose, HBA1c, Cholesterol, Triglycerides, HDL-cholesterol, LDL-cholesterol concentrations.
Results
FGF21 concentration is doubled in diabetics. (both men and women). independently from the patients’ age. and it was statistically significant. No statistical correlation between FGF21 and other biochemical markers in diabetic and non-diabetic individuals. as well as within the two subgroups of participants aged 40 years old was recorded.
Conclusion
FGF21 is an important metabolic regulator, which its concentration was found increased in diabetics serum, in the present study, while no statistical correlation was found between FGF21, age of the participants and other biochemical markers.
Zitieren
APA
Trapali, M., Karkalousos, P., Dogkas, N., & Karikas, G. A. (2025). Fibroblast growth factor 21 serum levels in diabetes mellitus patients: assessment of their correlation with carbohydrate and lipid metabolism markers. Review of Clinical Pharmacology and Pharmacokinetics - International Edition. https://doi.org/10.61873/bbdf1129
Vancouver
Trapali M, Karkalousos P, Dogkas N, Karikas GA. Fibroblast growth factor 21 serum levels in diabetes mellitus patients: assessment of their correlation with carbohydrate and lipid metabolism markers. Review of Clinical Pharmacology and Pharmacokinetics - International Edition. 2025. doi:10.61873/bbdf1129
BibTeX
@article{Trapali2025,
author = {Trapali, Maria and Karkalousos, Petros and Dogkas, Nikos and Karikas, George Albert},
title = {Fibroblast growth factor 21 serum levels in diabetes mellitus patients: assessment of their correlation with carbohydrate and lipid metabolism markers},
journal = {Review of Clinical Pharmacology and Pharmacokinetics - International Edition},
year = {2025},
doi = {10.61873/bbdf1129}
}
EUVIMED